Drulovic, J.; Tamas, O.; Nikolovski, N.; Momcilovic, N.; Radisic, V.; Andabaka, M.; Jevtic, B.; Stegnjaic, G.; Lazarevic, M.; Veselinovic, N.;
et al. Vaccine-Induced Humoral and Cellular Response to SARS-CoV-2 in Multiple Sclerosis Patients on Ocrelizumab. Vaccines 2025, 13, 488.
https://doi.org/10.3390/vaccines13050488
AMA Style
Drulovic J, Tamas O, Nikolovski N, Momcilovic N, Radisic V, Andabaka M, Jevtic B, Stegnjaic G, Lazarevic M, Veselinovic N,
et al. Vaccine-Induced Humoral and Cellular Response to SARS-CoV-2 in Multiple Sclerosis Patients on Ocrelizumab. Vaccines. 2025; 13(5):488.
https://doi.org/10.3390/vaccines13050488
Chicago/Turabian Style
Drulovic, Jelena, Olivera Tamas, Neda Nikolovski, Nikola Momcilovic, Vanja Radisic, Marko Andabaka, Bojan Jevtic, Goran Stegnjaic, Milica Lazarevic, Nikola Veselinovic,
and et al. 2025. "Vaccine-Induced Humoral and Cellular Response to SARS-CoV-2 in Multiple Sclerosis Patients on Ocrelizumab" Vaccines 13, no. 5: 488.
https://doi.org/10.3390/vaccines13050488
APA Style
Drulovic, J., Tamas, O., Nikolovski, N., Momcilovic, N., Radisic, V., Andabaka, M., Jevtic, B., Stegnjaic, G., Lazarevic, M., Veselinovic, N., Budimkic, M., Mesaros, S., Miljkovic, D., & Pekmezovic, T.
(2025). Vaccine-Induced Humoral and Cellular Response to SARS-CoV-2 in Multiple Sclerosis Patients on Ocrelizumab. Vaccines, 13(5), 488.
https://doi.org/10.3390/vaccines13050488
